FundedIQ
Biotechnology

Baseimmune: Funding, Investors & Team (Oct 2026)

Baseimmune is a biotech startup founded to create the next generation of vaccines.

www.baseimmune.co.uk LinkedIn London, United Kingdom 1-10 employees
Biotechnology Life Science
Total raised
$17.1M
Rounds
3
Latest
Series A
Feb 2024

Baseimmune has raised $17.1M across 3 funding rounds on record, the most recent a Series A of $11.4M announced in Feb 2024.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Baseimmune Company Profile and Key Stats

Total funding raised
$17.1M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Series A
$11.4M in Feb 2024
Employees
1-10
reported band
Headquarters
London, United Kingdom

Latest funding round on record: Feb 2024.

Baseimmune Funding Rounds

Date
Round
Amount
Series A
$11.4M
Seed
$4.8M
Seed
$900k

Baseimmune raised $900k in a Seed announced in Apr 2021.

7 months later, a Seed of $4.8M was announced in Nov 2021.

2.3 years later, a Series A of $11.4M was announced in Feb 2024.

Baseimmune Founders and Leadership Team

Name
Role
Contact
Ariane Gomes
Founder
Locked
Joshua Blight
CEO
Locked

Contact details for the Baseimmune team: 2 of 2 have an email address on file.

Start 14-day free trial →

Baseimmune Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
5,368
$4.1M
8,591
$15M

Baseimmune's latest round of $11.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Baseimmune in Biotechnology and London

Companies Similar to Baseimmune

Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…

Series C $40.4M

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…

Series C $310M

HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…

Series A $8.0M

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

Baseimmune Funding FAQs

What does Baseimmune do?

Baseimmune is a biotech startup founded to create the next generation of vaccines.

How much funding has Baseimmune raised?

Baseimmune has raised $17.1M across 3 rounds on record. The most recent is a Series A of $11.4M announced in Feb 2024.

When did Baseimmune last raise funding?

Baseimmune's most recent funding round on record is a Series A of $11.4M, announced in Feb 2024.

Who founded Baseimmune?

FundedIQ lists Ariane Gomes (Founder) at Baseimmune.

Who is the CEO of Baseimmune?

Joshua Blight is listed as CEO at Baseimmune.

Where is Baseimmune headquartered?

Baseimmune is based in London, England, United Kingdom.

How many employees does Baseimmune have?

Baseimmune is in the 1-10 employee band.

How does Baseimmune's funding compare to other Biotechnology startups?

Baseimmune's latest round of $11.4M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Baseimmune Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Baseimmune is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.